Cardiovascular complications of immunosuppressive agents in renal transplant recipients

Author： Olyaei Ali J   deMattos Angelo M   Bennett William M  

Publisher： Informa Healthcare

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.4, Iss.1, 2005-01, pp. : 29-44

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of Immunosuppressive Agents on Long-Term Survival of Renal Transplant Recipients: Focus on the Cardiovascular Risk

By Johannes M.M. Boots   Maarten H.L. Christiaans   Johannes P. van Hooff  

Drugs, Vol. 64, Iss. 18, 2004-01 ,pp. : 2047-2073

Adis International

Access to resources Recommend Favorite

The Role of Immunosuppressive Medications in the Pathogenesis of Hypertension and Efficacy and Safety of Antihypertensive Agents in Kidney Transplant Recipients

By  

Current Medicinal Chemistry, Vol. 23, Iss. 19, 2016-07 ,pp. : 1941-1952

Bentham Science Publishers

Access to resources Recommend Favorite

Economic Impact and Long-Term Graft Outcomes of Mycophenolate Mofetil Dosage Modifications Following Gastrointestinal Complications in Renal Transplant Recipients

By Machnicki Gerardo  

PharmacoEconomics, Vol. 26, Iss. 11, 2008-01 ,pp. : 951-967

Adis International

Access to resources Recommend Favorite

Immunosuppressive Therapy and Malignancy in Organ Transplant Recipients: A Systematic Review

By Gutierrez-Dalmau Alex   Campistol Josep M.  

Drugs, Vol. 67, Iss. 8, 2007-01 ,pp. : 1167-1198

Adis International

Access to resources Recommend Favorite

Induction Therapy in Pediatric Renal Transplant Recipients: An Overview

By Moudgil Asha  

Pediatric Drugs, Vol. 9, Iss. 5, 2007-01 ,pp. : 323-341

Adis International

Access to resources Recommend Favorite